论文部分内容阅读
尼莫的平是双氢吡啶衍生物,不溶于水,属脂溶性化脑功能紊乱等有良好的治疗效果.是国际上公认的治疗脑合物.易透过血脑屏障选择性扩张脑血管.无“窃血”现象,血管疾病的首选药物,尼莫的平在适宜剂量下选择性扩张增加脑血流量的同时几乎不影响脑代谢.并且还具有降低脑血管.几乎不影响外周血管.但增加剂量对心绞痛和高血浆粘稠性和抑制血小板聚集作用.可拮抗多种介质诱发血压也有较好的疗效,其不良反应较微.偶见胃肠道不适的脑血管痉挛。对蛛网膜下腔出血、偏头痛、脑卒中、突发一过性头晕及皮肤潮红,并且停药后即消失。性耳聋、失血性和创伤性休克以及慢性脑血管疾患所致的
Nimodipine is a dihydropyridine derivative, insoluble in water, is a fat-soluble brain dysfunction, etc. have a good therapeutic effect is internationally recognized treatment of brain compounds easily through the blood-brain barrier selectively dilated cerebrovascular Without “steal”, the first choice of vascular disease, nimotopin selectively expands at the appropriate dose to increase cerebral blood flow with little or no effect on brain metabolism, and also has reduced cerebral blood vessels with little or no effect on peripheral blood vessels. However, increasing the dose of angina pectoris and high plasma viscosity and inhibition of platelet aggregation can antagonize a variety of media-induced blood pressure also has a good effect, the adverse reaction is mild.Inthere gastrointestinal discomfort of cerebral vasospasm. Subarachnoid hemorrhage, migraine, stroke, sudden transient dizziness and skin flushing, and disappear after withdrawal. Deafness, hemorrhagic and traumatic shock, and chronic cerebrovascular disease